Study of the Safety and Efficacy of the Subunit Recombinant Tuberculosis Vaccine GamTBvac
- First Posted Date
- 2021-07-23
- Last Posted Date
- 2022-11-30
- Lead Sponsor
- Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
- Target Recruit Count
- 7180
- Registration Number
- NCT04975737
- Locations
- ๐ท๐บ
City hospital #40, Saint Petersburg, Russian Federation
Study of Gam-COVID-Vac in Adolescents
- Conditions
- Interventions
- First Posted Date
- 2021-07-08
- Last Posted Date
- 2021-09-16
- Lead Sponsor
- Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
- Target Recruit Count
- 3000
- Registration Number
- NCT04954092
- Locations
- ๐ท๐บ
Children's City Clinical Hospital named after Z.A. Bashlyaeva of the Moscow Department of Health, Moscow, Russian Federation
๐ท๐บMorozovskaya Children's City Clinical Hospital of the Moscow Department of Health, Moscow, Russian Federation
Study to Evaluate Efficacy, Immunogenicity and Safety of the Sputnik-Light
- First Posted Date
- 2021-02-05
- Last Posted Date
- 2021-02-21
- Lead Sponsor
- Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
- Target Recruit Count
- 6000
- Registration Number
- NCT04741061
- Locations
- ๐ท๐บ
Federal state budgetary educational Institution for Higher Education "Saratov State Medical University named after V.I. Razumovskiy" Ministry of Health of Russian Federation, Saratov, Russian Federation
๐ท๐บState Budgetary Healthcare Institution, Moscow, Consultation and Diagnosis Polyclinic No. 121, Moscow Healthcare Department, Moscow, Russian Federation
๐ท๐บState Budgetary Healthcare Institution, Moscow, Municipal Polyclinic No. 210, Moscow Healthcare Department, Moscow, Russian Federation
An Open Study of the Safety and Pharmacokinetics of a Drug for the Emergency Prevention of Ebola Virus Disease
- First Posted Date
- 2021-01-22
- Last Posted Date
- 2021-02-18
- Lead Sponsor
- Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
- Target Recruit Count
- 25
- Registration Number
- NCT04717830
- Locations
- ๐ท๐บ
Research Institute of Influenza, Sankt-Peterburg, Russian Federation
An Open Study on the Safety, Tolerability, and Immunogenicity of "Sputnik Light" Vaccine
- First Posted Date
- 2021-01-19
- Last Posted Date
- 2021-02-02
- Lead Sponsor
- Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
- Target Recruit Count
- 110
- Registration Number
- NCT04713488
- Locations
- ๐ท๐บ
ECO-Safety, Sankt Peterburg, Russian Federation
A Phase III Clinical Trial of the Immunogenicity and Safety of the Gam-COVID-Vac Vaccine Against COVID-19 in the UAE
- First Posted Date
- 2020-12-07
- Last Posted Date
- 2020-12-07
- Lead Sponsor
- Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
- Target Recruit Count
- 1000
- Registration Number
- NCT04656613
Clinical Trial of the Immunogenicity, Safety, and Efficacy of the Gam-COVID-Vac Vaccine Against COVID-19 in Venezuela
- First Posted Date
- 2020-11-24
- Last Posted Date
- 2020-11-24
- Lead Sponsor
- Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
- Target Recruit Count
- 2000
- Registration Number
- NCT04642339
The Study of "Gam-COVID-Vac" Vaccine Against COVID-19 With the Participation of Volunteers of 60 y.o and Older
- First Posted Date
- 2020-10-14
- Last Posted Date
- 2021-01-22
- Lead Sponsor
- Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
- Target Recruit Count
- 110
- Registration Number
- NCT04587219
- Locations
- ๐ท๐บ
Federal state budgetary institution "Central clinical hospital with polyclinic" Of the office Of the President of the Russian Federation, Moscow, Russian Federation
Clinical Trial of Efficacy, Safety, and Immunogenicity of Gam-COVID-Vac Vaccine Against COVID-19 in Belarus
- First Posted Date
- 2020-09-25
- Last Posted Date
- 2020-12-02
- Lead Sponsor
- Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
- Target Recruit Count
- 100
- Registration Number
- NCT04564716
- Locations
- ๐ง๐พ
Health Institution "19th Central Regional Polyclinic of the Pervomaysk district of Minsk", Minsk, Belarus
๐ง๐พHealth Institution "5th City Clinical Polyclinic of Minsk", Minsk, Belarus
๐ง๐พHealth Institution "14th Central Regional Polyclinic of the Partisan district of Minsk", Minsk, Belarus
Clinical Trial of Efficacy, Safety, and Immunogenicity of Gam-COVID-Vac Vaccine Against COVID-19
- First Posted Date
- 2020-08-28
- Last Posted Date
- 2021-01-22
- Lead Sponsor
- Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
- Target Recruit Count
- 33758
- Registration Number
- NCT04530396
- Locations
- ๐ท๐บ
ARCHIMED V Clinic of new medical technologies limited liability company, Moscow, Russian Federation
๐ท๐บMedsi Group of companies joint-stock company", Moscow, Russian Federation
๐ท๐บState Budgetary Healthcare Institution, Moscow, Municipal Polyclinic No. 219, Moscow Healthcare Department, Moscow, Russian Federation